John Douglas Young's most recent trade in Johnson Controls International plc - Registered Shares was a trade of 2,287 Ordinary Shares done . Disclosure was reported to the exchange on March 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Johnson Controls Internati... | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,287 | 18,244 (0%) | 0% | 0 | Ordinary Shares | |
Johnson Controls Internati... | John Douglas Young | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.68 per share. | 12 Mar 2025 | 1,416 | 16,828 (0%) | 0% | 78.7 | 111,411 | Ordinary Shares |
Arvinas Inc | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,070 | 9,070 | - | - | Stock Option (right to buy) | |
Arvinas Inc | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 5,899 | 10,020 (0%) | 0% | 0 | Common Stock | |
Johnson Controls Internati... | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 2,889 | 15,700 (0%) | 0% | 0 | Ordinary Shares | |
Johnson Controls Internati... | John Douglas Young | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.73 per share. | 09 Mar 2024 | 1,401 | 12,811 (0%) | 0% | 61.7 | 86,484 | Ordinary Shares |
Arvinas Inc | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,787 | 12,787 | - | - | Stock Option (right to buy) | |
Arvinas Inc | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,121 | 4,121 (0%) | 0% | 0 | Common Stock | |
Johnson Controls Internati... | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 2,843 | 13,874 (0%) | 0% | 0 | Ordinary Shares | |
Johnson Controls Internati... | John Douglas Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.46 per share. | 08 Mar 2023 | 1,372 | 11,031 (0%) | 0% | 63.5 | 87,067 | Ordinary Shares |
Arvinas Inc | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 24,572 | 24,572 | - | - | Stock Option (right to buy) | |
Johnson Controls Internati... | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 2,786 | 13,507 (0%) | 0% | 0 | Ordinary Shares | |
Johnson Controls Internati... | John Douglas Young | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.81 per share. | 09 Mar 2022 | 1,398 | 12,109 (0%) | 0% | 62.8 | 87,808 | Ordinary Shares |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 8 | 53,635 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 8 | 53,645 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 9 | 53,698 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 11 Nov 2021 | 47,782 | 312,704 (0%) | 0% | 50.0 | 2,389,578 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.02 per share. | 11 Nov 2021 | 30,200 | 360,486 (0%) | 0% | 50.0 | 1,510,604 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 11 Nov 2021 | 15,500 | 390,686 (0%) | 0% | 50.1 | 776,860 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 11 Nov 2021 | 11,700 | 406,186 (0%) | 0% | 50.1 | 586,170 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.07 per share. | 11 Nov 2021 | 9,818 | 417,886 (0%) | 0% | 50.1 | 491,587 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.15 per share. | 11 Nov 2021 | 9,500 | 427,704 (0%) | 0% | 50.2 | 476,425 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.14 per share. | 11 Nov 2021 | 9,100 | 437,204 (0%) | 0% | 50.1 | 456,274 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.06 per share. | 11 Nov 2021 | 6,200 | 446,304 (0%) | 0% | 50.1 | 310,372 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.03 per share. | 11 Nov 2021 | 4,200 | 452,504 (0%) | 0% | 50.0 | 210,126 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.09 per share. | 11 Nov 2021 | 3,200 | 456,704 (0%) | 0% | 50.1 | 160,288 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 11 Nov 2021 | 2,800 | 459,904 (0%) | 0% | 50.2 | 140,448 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 10 | 53,316 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 11 | 53,329 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2021 | 36 | 53,315 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 10 | 53,271 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 10 | 53,249 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 10 | 53,238 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2021 | 9 | 53,194 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 10 | 53,291 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 11 | 52,834 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 38 | 52,827 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 11 | 52,798 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 11 | 52,785 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 11 | 52,791 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 May 2021 | 8,830 | 461,761 (0%) | 0% | 0 | Common Stock | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 11 | 52,751 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 11 | 52,247 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12 | 52,245 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 223 | 52,239 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 12 | 52,021 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 402 | 52,021 | - | - | Phantom Stock Units SSP | |
Johnson Controls Internati... | John Douglas Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 2,864 | 10,551 (0%) | 0% | 0 | Ordinary Shares | |
Johnson Controls Internati... | John Douglas Young | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.20 per share. | 05 Mar 2021 | 2,222 | 7,687 (0%) | 0% | 59.2 | 131,542 | Ordinary Shares |
Pfizer Inc. | John Douglas Young | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 129,419 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | John Douglas Young | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. | 27 Feb 2021 | 129,419 | 575,282 (0%) | 0% | 22.4 | 2,892,515 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.64 per share. | 27 Feb 2021 | 82,057 | 470,031 (0%) | 0% | 34.6 | 2,842,454 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.49 per share. | 27 Feb 2021 | 23,194 | 552,088 (0%) | 0% | 33.5 | 776,767 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2021 | 163,334 | 579,791 (0%) | 0% | 22.9 | 3,738,715 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 163,334 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 140,465 | 140,465 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 121,366 | 121,366 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | John Douglas Young | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 25 Feb 2021 | 105,707 | 445,863 (0%) | 0% | 34.8 | 3,674,375 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.82 per share. | 25 Feb 2021 | 28,221 | 551,570 (0%) | 0% | 33.8 | 954,434 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 698 | 51,624 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 39 | 50,338 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 12 | 50,299 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.05 per share. | 29 Dec 2020 | 10,607 | 415,947 (0%) | 0% | 37.0 | 392,989 | Common Stock |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 11 | 50,272 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 11 | 50,294 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2020 | 11 | 47,807 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 12 | 47,359 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 12 | 47,342 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2020 | 40 | 47,328 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 12 | 47,291 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 12 | 47,278 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 11 | 47,252 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 11 | 47,232 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 11 | 47,212 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2020 | 12 | 46,778 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 44 | 46,785 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 13 | 46,751 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 13 | 46,751 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 13 | 46,731 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 11 | 46,632 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 11 | 46,636 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Apr 2020 | 7,910 | 421,072 (0%) | 0% | 0 | Common Stock | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 11 | 46,158 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 12 | 46,167 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2020 | 222 | 46,175 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | John Douglas Young | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 13 | 45,971 | - | - | Phantom Stock Units SSP |